News
LVZPF
4.350
NaN%
--
CICC Reaffirms Their Buy Rating on Livzon Pharmaceutical Group (LVZPF)
TipRanks · 1d ago
Livzon Wins NMPA Nod for JP-1366 H. pylori Trial, Deepening GI Drug Portfolio
TipRanks · 6d ago
Livzon Pharmaceutical Schedules Board Meeting to Review First-Quarter 2026 Results
TipRanks · 04/08 09:19
Livzon Clarifies 2025 Dividend Plan, Confirms RMB14.30 per 10 Shares
TipRanks · 03/26 12:16
Livzon Wins NMPA Nod to Trial Long-Acting Brexpiprazole for Schizophrenia
TipRanks · 03/26 11:41
Livzon Pharmaceutical Strengthens Board Committees With New Appointments
TipRanks · 03/24 13:41
Livzon Pharmaceutical Outlines Board and Committee Structure
TipRanks · 03/24 13:41
Livzon Pharmaceutical Proposes Final 2025 Dividend of RMB 14.3 per 10 Shares
TipRanks · 03/24 13:40
Livzon Pharmaceutical Publishes Audited 2025 Results and Annual Report
TipRanks · 03/24 13:08
Livzon Pharmaceutical Cuts Registered Capital and Streamlines Board Structure
TipRanks · 03/24 13:07
Livzon Wins Vietnam Approval for Tender Offer for Imexpharm Shares
TipRanks · 03/06 11:09
Livzon Pharmaceutical Sets March Board Meeting to Approve 2025 Annual Results
TipRanks · 03/02 09:17
Livzon Pharmaceutical Announces Senior Leadership Reshuffle and Board Changes
TipRanks · 03/01 10:40
Livzon Pharmaceutical Group Details Board and Committee Structure
TipRanks · 03/01 10:39
Livzon downgraded to Sell from Neutral at Goldman Sachs
TipRanks · 02/05 16:15
Livzon’s Psoriasis Biologic Lecankitug Enters China’s Priority Review Channel
TipRanks · 01/07 11:08
Livzon Pharmaceutical Trims Stake in Fluffy Buddy Through Connected Deemed Disposal
TipRanks · 12/30/2025 10:39
Livzon Extends Deadline and Launches Tender Offer Plan for Vietnam’s Imexpharm
TipRanks · 12/30/2025 10:38
Livzon Pharmaceutical Sets 2026 Caps on Connected Transactions With Livzon MAB
TipRanks · 12/30/2025 10:09
Livzon Sets 2026 Caps for Connected Transactions With Controlling Shareholder Joincare
TipRanks · 12/30/2025 10:08
More
Webull provides a variety of real-time LVZPF stock news. You can receive the latest news about Livzon Pharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About LVZPF
Livzon Pharmaceutical Group Inc is a China-based company principally engaged in the research, development, production and sale of pharmaceutical products. The Company's main businesses include chemical drug preparations, biological products, active pharmaceutical ingredients and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, commercial development and functional management. The Company's main products include Ilaprazole (Ilaprazole Enteric-Coated Tablets and Ilaprazole Sodium for Injection), a series of Bismuth Potassium Citrate products, Rabeprazole Sodium Enteric-Coated Capsules, Weisanlian (Bismuth Potassium Citrate Tablets/Tinidazole Tablets/Clarithromycin Tablets), Leuprorelin Acetate Microspheres for Injection, Urofollitropin for Injection, Menotropins for Injection, Voriconazole for Injection and others. The Company mainly operates its businesses in the domestic and overseas markets.